[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368862-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368862-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","does-microtubule-motor-mediated-centrosomal-dyshomeostasis-confer-chemoresistance-in-breast-cancer","Does microtubule motor-mediated centrosomal dyshomeostasis confer chemoresistance in breast cancer?","","Chemoresistance undermines effective chemotherapy for breast cancer, yet the exact molecular drivers remain unclear. Clustered supernumerary centrosomes, arising from centrosome over-duplication, represent a dysregulated hallmark in many cases. Microtubule motor proteins (MiMos) preserve centrosome integrity by coordinating cohesion, separation, and centrosome positioning. Differential MiMo expression in chemoresistant tumors suggests a link. This review proposes that MiMo-associated centrosomal dysregulation promotes chemoresistance, supported by a systematic review narrowing to sixteen MiMos (one dynein, fifteen kinesins).",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/does-microtubule-motor-mediated-centrosomal-dyshomeostasis-confer-chemoresistance-in-breast-cancer/368862/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/does-microtubule-motor-mediated-centrosomal-dyshomeostasis-confer-chemoresistance-in-breast-cancer/368862.png","ImageObject",300,407,{"name":42,"@type":43},"Aldword","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the paper address in breast cancer treatment?","Question",{"text":63,"@type":64},"The paper addresses chemoresistance, a major obstacle to effective chemotherapy in breast cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What centrosome-related feature is highlighted as common in many breast cancers?",{"text":68,"@type":64},"Many breast cancers show clustered supernumerary centrosomes, linked primarily to centrosome over-duplication.",{"name":70,"@type":61,"acceptedAnswer":71},"How do microtubule motor proteins (MiMos) relate to centrosome behavior?",{"text":72,"@type":64},"MiMos maintain centrosome integrity by regulating cohesion, separation, and positioning of centrosomes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368862,1790218598,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336478940917,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Journal of Mammary Gland Biology and Neoplasia (2025) 30:14  \n[https://doi.org/10.1007/s1091](https://doi.org/10.1007/s1091) 1-025-09585-5  \nREVIEW  \nDoes microtubule motor-mediated centrosomal dyshomeostasis confer chemoresistance in breast cancer?  \nJ. Priyanga1 · Gunjan Guha1 · Dipita Bhakta-Guha1  \nReceived: 4 March 2025 / Accepted: 20 June 2025 © The Author(s) 2025  \nAbstract  \nChemoresistance is a major challenge in effective chemotherapy for breast cancers. Unfortunately, the precise molecular mechanisms that confer resistance remain elusive so far. A remarkable feature in a multitude of breast cancers is the presence of clustered supernumerary centrosomes, which is a dysregulated condition that arises primarily through centrosome over-duplication. Normally, microtubule motor proteins (MiMos) maintain the integrity of centrosomes via regulating cohesion, separation and positioning of centrosomes. In the recent years, several MiMos have been reported to be differentially expressed in chemoresistant breast cancers. Such findings suggest a probable association of MiMos with chemoresistance. Here, we propose that MiMo-associated centrosomal dysregulation is involved in conferring chemoresistance in breast cancers. We corroborate the same with a systematic review of literature where we narrow down to sixteen MiMos (one dynein and fifteen kinesins) . Our argument highlights a plausible decisive role of MiMo-mediated centrosomal anomalies in orchestrating chemoresistance in breast cancers.  \nKeywords Breast cancer · Chemoresistance · Centrosomal Dyshomeostasis · Supernumerary Centrosomes · Microtubule Motor Proteins · Systematic Review  \nIntroduction  \nBreast cancer is one of the leading causes of death among women and, in 2020 alone, claimed around 0.685 million lives worldwide [1] . At present, the common intervention modalities for breast cancer include chemotherapy, surgery, radiation and endocrine therapy, where chemotherapy dominates as the most adopted approach [2, 3] . Taxanes (docetaxel and paclitaxel) and anthracyclines (doxorubicin, epirubicin, etc.), are some of the first line of chemotherapeutics that showcase considerable efficacy across different stages/grades of breast cancer [4–7] . However, a major challenge that plagues this approach is the development of chemoresistance by cancer cells. This not only renders the  \n􀀍 Gunjan Guha  \n[gunjan.doc@gmail.com](gunjan.doc@gmail.com); [gunjanguha@scbt.sastra.edu](gunjanguha@scbt.sastra.edu)  \n􀀍 Dipita Bhakta-Guha  \n[dipita2001@gmail.com](dipita2001@gmail.com); [dipitaguha@scbt.sastra.edu](dipitaguha@scbt.sastra.edu)  \n1 Department of Biotechnology, Cellular Dyshomeostasis Laboratory, School of Chemical and Bio Technology, SASTRA University, Thanjavur, Tamil Nadu613 401, India  \nprima facie treatment ineffective, but also augments the risk of relapse along with lowered survival probability in the patients [8, 9] . Hence, understanding the mechanisms that are involved in the development of chemoresistance can ensure implementation of strategies aimed at sustained sensitization of cancer cells to chemotherapy. This, in turn, will enable us toward a plausible progress in the cancer therapy paradigm and subsequently drive ourselves forward in achieving ‘good health and well being’ – one of the seventeen sustainable development goals of the United Nations (UN-SDG) [10] .  \nAkin to the etiology of cancer, rise of chemoresistance, in cancer cells, is a consequence of complex dysregulation of various cellular facets [11, 12] . In case of breast cancer cells, among a host of functional proteins which participate in the development of chemoresistance, a few critical centrosome-associated proteins have been reported to be deregulated [13–15] . This suggests that centrosomal anomalies might play a decisive role in promoting chemoresistance in breast cancers. However, the precise role of dysregulated centrosomal function in chemoresistance is still obscure.  \nCentrosome, present i","cbCaidBrNKgrSy8x","https://ap.wps.com/l/cbCaidBrNKgrSy8x","pdf",1481828,11,"English","# Abstract\n# Keywords\n# Introduction","[{\"question\":\"What problem does the paper address in breast cancer treatment?\",\"answer\":\"The paper addresses chemoresistance, a major obstacle to effective chemotherapy in breast cancer.\"},{\"question\":\"What centrosome-related feature is highlighted as common in many breast cancers?\",\"answer\":\"Many breast cancers show clustered supernumerary centrosomes, linked primarily to centrosome over-duplication.\"},{\"question\":\"How do microtubule motor proteins (MiMos) relate to centrosome behavior?\",\"answer\":\"MiMos maintain centrosome integrity by regulating cohesion, separation, and positioning of centrosomes.\"}]","Does microtubule motor-mediated centrosomal dyshomeostasis confer chemoresistance in breast cancer? | PDF",1790178966,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/026a153ba32b93b1c0e29b861f357e5d.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d5969d445d64281c0c70691572055e63.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fa525a6a078fda6793596c385b96eec9.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/349aacd3114eaea56e669c0133fe1767.webp",980,1301]